Investigational: NEO 102 is a monoclonal antibody, not what is usually meant by the word chemotherapy. It is the subject of ongoing clinical trials. Therefore it is not yet known whether the drug is useful, harmful, or indifferent. In the U.S. it would only be available for subjects in a clinical trial. I suspect, but am not certain, that that is true in the U.K. Too.
Answered 1/31/2015
3.3k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question